Selected data models

You must log in to select data models for download or further analysis.

34 Search results.
Relevance Rating New first Old first

Eligibility Leukemia NCT01046305

- 5/22/18 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Symptom Burden in Chronic Myeloid Leukemia (CML); ODM derived from: https://clinicaltrials.gov/show/NCT01046305

Eligibility Leukemia NCT00446173

- 5/16/18 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Autologous Stem Cell Transplants for Chronic Myelogenous Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00446173

Eligibility Leukemia NCT00362466

- 5/16/18 - 1 form, 2 itemgroups, 14 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of Dasatinib vs. High-Dose Imatinib (600 mg) in Patients With Chronic Phase Chronic Myeloid Leukemia (CML) Who Failed to Achieve Complete Cytogenetic Response After 3-18 Months of Imatinib Therapy; ODM derived from: https://clinicaltrials.gov/show/NCT00362466

Eligibility Leukemia NCT00466726

- 8/3/17 - 1 form, 1 itemgroup, 22 items, 1 language
Itemgroup: Criteria
Vaccine Therapy in Treating Patients With Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00466726

Eligibility Leukemia NCT00529763

- 3/6/17 - 1 form, 3 itemgroups, 16 items, 1 language
Itemgroups: Criteria, Inclusion Criteria, Exclusion Criteria
Dasatinib in Imatinib Resistant/Intolerant Chinese CML (Chronic and Advanced Phase) Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00529763

Eligibility Chronic Myeloid Leukemia NCT02398825

- 3/1/19 - 1 form, 2 itemgroups, 28 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Activity and Risk Profile of Ponatinib in Chronic Phase Patients With Chronic Myeloid Leukemia Resistant to Imatinib; ODM derived from: https://clinicaltrials.gov/show/NCT02398825

Eligibility Chronic Myeloid Leukemia NCT02011945

- 12/12/18 - 1 form, 3 itemgroups, 7 items, 1 language
Itemgroups: Criteria, Inclusion Criteria, Exclusion Criteria
A Phase 1B Study to Investigate the Safety and Preliminary Efficacy for the Combination of Dasatinib Plus Nivolumab in Patients With Chronic Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT02011945

Eligibility Chronic Myeloid Leukemia NCT01073436

- 12/16/17 - 1 form, 2 itemgroups, 18 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha; ODM derived from: https://clinicaltrials.gov/show/NCT01073436

Eligibility Chronic Myeloid Leukemia NCT00947830

- 12/15/17 - 1 form, 2 itemgroups, 12 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00947830

Eligibility Chronic Myeloid Leukemia NCT00866736

- 12/15/17 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
A Study of Dasatinib in Patients With Imatinib Resistant or Intolerant Chronic Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00866736

Eligibility Myeloid Leukemia, Chronic NCT00478985

- 8/14/17 - 1 form, 2 itemgroups, 11 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00478985

Eligibility Leukemia, Myeloid, Chronic NCT00320190

- 4/21/17 - 1 form, 2 itemgroups, 10 items, 1 language
Itemgroups: Inclusion Criteria, Exclusion Criteria
Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib; ODM derived from: https://clinicaltrials.gov/show/NCT00320190

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial